211 related articles for article (PubMed ID: 19958118)
1. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.
Varshosaz J; Tabbakhian M; Mohammadi MY
J Liposome Res; 2010 Dec; 20(4):286-96. PubMed ID: 19958118
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
Varshosaz J; Minayian M; Moazen E
J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
Hu L; Tang X; Cui F
J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
[TBL] [Abstract][Full Text] [Related]
5. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
7. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
Hu L; Jia H; Luo Z; Liu C; Xing Q
Pharmazie; 2010 Feb; 65(2):110-3. PubMed ID: 20225654
[TBL] [Abstract][Full Text] [Related]
8. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.
Dhawan S; Kapil R; Singh B
J Pharm Pharmacol; 2011 Mar; 63(3):342-51. PubMed ID: 21749381
[TBL] [Abstract][Full Text] [Related]
9. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP
Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
[TBL] [Abstract][Full Text] [Related]
10. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
11. Development and optimization of solid lipid nanoparticles of amikacin by central composite design.
Varshosaz J; Ghaffari S; Khoshayand MR; Atyabi F; Azarmi S; Kobarfard F
J Liposome Res; 2010 Jun; 20(2):97-104. PubMed ID: 19621981
[TBL] [Abstract][Full Text] [Related]
12. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H
J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
Zhang T; Chen J; Zhang Y; Shen Q; Pan W
Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles.
Jee JP; Lim SJ; Park JS; Kim CK
Eur J Pharm Biopharm; 2006 Jun; 63(2):134-9. PubMed ID: 16527470
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
Dudhipala N; Veerabrahma K
Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
[TBL] [Abstract][Full Text] [Related]
19. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies.
Shah M; Chuttani K; Mishra AK; Pathak K
Drug Dev Ind Pharm; 2011 May; 37(5):526-37. PubMed ID: 21128704
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
[Next] [New Search]